In addition, a missense variant in nuclear receptor co-activator NCOA3, causing increased expression of inflammatory mediators in microglial cells (Fig 5D), was identified in three multi-incident MS families (Fig 2). Here, NCOA3 is linked to myeloid sarcoma.